BHVN
Biohaven Ltd.stockNYSE
Market OpenNov 19, 2026 9:44:28 AM EST
13.48USD+4.457%(+0.58)280,933
Pre-marketNov 19, 2026 9:01:30 AM EST
13.20USD+2.326%(+0.30)
BHVN News
Biohaven advances Graves’ disease drug trial, presents research ·
Investing.com
Biohaven Q3 Loss Narrows as FDA Accepts Vyglxia NDA Resubmission ·
Securities.io
March 2027 Options Now Available For Biohaven (BHVN) ·
BNK Invest
Biggest stock movers Thursday: TSLA, BABA, TTMI, PG, and more ·
Seeking Alpha
Why Biohaven Catapulted 25% — And Why It Might Not Be Done Sprinting ·
Investor's Business Daily
Why is Biohaven stock surging today? ·
Investing.com
Biohaven stock surges 25% on FDA acceptance of drug filing ·
Investing.com
Biohaven partners with Ono in $100m IgG degrader deal ·
Pharmaceutical Technology
